| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0055 | 0.9 |